A Pilot Study on the Safety and Efficacy of YOLT-204 for Transfusion-Dependent Beta-Thalassemia

NCT06678165 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Transfusion Dependent Beta Thalassemia

Interventions

DRUG: YOLT-204

Sponsor

First Affiliated Hospital of Guangxi Medical University